Biotech HOLDRs Trust Down 15.6% Since SmarTrend Downtrend Call (BBH)
Comtex SmarTrend(R) - Mon Apr 14, 11:09AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 1 month, Biotech HOLDRs Trust has returned 15.63% as of today's recent price of $84.44.
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Apr 11, 9:01AM CDT
Biotech ETFs have been crashing, but have all the funds been performing the same in the space?
Biotech HOLDRs Trust Has Returned 12.0% Since SmarTrend Recommendation (BBH)
Comtex SmarTrend(R) - Mon Apr 07, 10:00AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 1 month, Biotech HOLDRs Trust has returned 12.04% as of today's recent price of $88.03.
Biotech HOLDRs Trust Shares Down 10.5% Since SmarTrend's Sell Call (BBH)
Comtex SmarTrend(R) - Mon Mar 31, 9:27AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 3 weeks, Biotech HOLDRs Trust has returned 10.52% as of today's recent price of $89.55.
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 24, 1:00PM CDT
The terrible trading in the biotech stock world sent these ETFs into deep red in Friday session.
The Guide to Surging Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 11:00AM CST
Investors should not ignore this high growth sector that continues to deliver strong performance
Intercept Pharma (ICPT) Pushes SPDR Biotech ETF Ahead of Rivals - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Jan 10, 6:54AM CST
Intercept Pharma added nearly 300% on the session, but not all biotech ETFs benefited equally.
The Best ETFs of 2013
Dan Caplinger, The Motley Fool - Motley Fool - Fri Dec 20, 4:55PM CST
Exchange-traded funds have maintained their immense popularity throughout the bull market as an increasing number of investors look at ETFs as a flexible, low-cost alternative to actively managed mutual funds. With thousands of different ETFs to...
How to Know if You Are Really a 'Value' Investor
at The Street - Wed Dec 11, 10:32AM CST
How many of us truly have the stomach or temperament for investing in the most hated of asset classes?
Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Dec 04, 11:04AM CST
After facing some turbulence lately, are biotechnology ETFs on the right path once more?
4 Ways to Play the Bullish Trend in Healthcare with ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Oct 30, 8:00AM CDT
Pharma and biotech ETFs could be interesting picks thanks to some positive trends in the space.
Top Ranked Biotech ETF in Focus: BBH - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 24, 7:00AM CDT
Should investors consider this biotechnology ETF for their portfolio?